• SENSEX 76,295.36
    -322.08 (--0.42%)
  • BANKNIFTY 51,597.35
    249.30 (+0.49%)
  • Mazagon Dock
    2,750.00 2,929.98(%)
  • Tejas Networks
    902.70 1,495.10(%)
  • Hind.Aeronautics
    4,328.95 5,675.00(%)
  • Kalyan Jewellers
    497.15 337.00(%)
  • Adani Power
    538.00 896.75(%)
  • TCS
    3,396.10 3,396.10(%)
  • Reliance Industr
    1,234.55 1,156.00(%)
  • Bharat Electron
    288.30 340.35(%)
  • Persistent Sys
    4,764.75 3,232.60(%)
  • Vodafone Idea
    8.06 6.60(%)
  • Tata Motors
    652.80 606.20(%)
  • Infosys
    1,485.10 1,359.10(%)
  • Angel One
    2,475.00 3,502.60(%)
  • Jio Financial
    231.75 394.70(%)
  • HDFC Bank
    1,776.70 1,430.15(%)
  • Nippon ETF Liq.
    1,000.01 1,005.00(%)
  • Reliance Power
    44.44 54.25(%)
  • Zomato Ltd
    208.35 146.85(%)
  • ICICI Pru. BSE
    999.99 998.75(%)
  • Emcure Pharma
    1,025.75 911.75(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Sequent Scientific Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • MNC Associate
  • BSE Code : 2086.0
  • ISIN : INE807F01027
142.68 6 (4.05%)
  • As on 03 Apr 2025 (EOD)

  • Today’s Low

    137.00

  • Today’s High

    144.50

  • Open

    137.00

  • Perv Close

    137.13

  • 52W Low

    92.05

  • 52W High

    240.70

Key Indicators

  • P/E(TTM)

    192.84

  • Mar.Cap (₹Cr.)

    3,571.31

  • Div & Yield %

    0.00

  • Book Value(₹)

    44.30

  • Debt-Equity Ratio

    4.05

  • AGM Date

    03-Apr-2025

  • EPS

    0.74

  • P/E Ratio

    192.84

Financials Ratios

  • Debt-Equity Ratio

    0.69

  • Mar.Cap (₹Cr.)

    3,571.31

  • RONW (%)

    -3.09

  • ROCE (%)

    0.45

Score Board

  • Equity (₹ in Cr.)

    50.06

  • BV (₹)

    44.30

  • Sales( ₹ in Cr.)

    168.52

  • NP (in Cr.)

    2.31

  • NP Var(%)

    138.0

  • Div%

    0.0

  • CPS (₹)

    0.40

  • EPS (₹)

    0.10

  • Traded Value (₹ in Lakhs)

    3,571.81

  • 52 Week High

    240.70

  • 52 Week Low

    92.05

  • Price BSE

    143.0

  • Price NSE

    143.00

  • Market Capital( in Cr.)

    3,571.81

  • P/C Ratio

    318.10

  • P/E Ratio

    1,548.80

  • Price Vs.BV

    0.10

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Sales Turnover 168.52 222.69 219.63 265.46 227.33 166.26
Excise Duty 157.71 212.26 215.98 261.82 223.33 161.37
Net Sales 168.52 222.69 219.63 265.46 227.33 166.26
Other Income 45.98 28.24 27.64 19.97 14.56 13.96
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 214.50 250.93 247.27 285.42 241.89 180.22
EXPENDITURE :
Raw Materials 157.71 212.26 215.98 261.82 223.33 161.37
Power & Fuel Cost 157.71 212.26 215.98 261.82 223.33 161.37
Employee Cost 30.05 36.66 27.38 22.42 17.10 10.71
Other Manufacturing Expenses 0.29 1.52 0.45 8.12 1.68 1.43
Selling & Administrative Expenses 17.86 19.49 19.40 20.27 9.98 8.36
Miscellaneous Expenses 0.29 1.52 0.45 8.12 1.68 1.43
Less : Pre-operative Expenses Capitalised :
Total Expenditure 208.48 260.67 231.58 241.98 219.08 174.01
Operating Profit 39.10 55.47 64.49 70.50 63.29 48.45
Interest 4.36 2.51 1.61 2.68 5.04 3.22
Gross Profit -0.24 -9.75 15.69 40.89 22.81 6.20
Depreciation 8.94 9.12 9.59 9.13 8.95 7.22
Profit Before Tax -0.24 -9.75 15.69 40.89 22.81 6.20
Tax 0.00 0.02 2.51 7.31 3.18 1.33
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -1.32 -3.09 0.52 2.69 -1.71 -1.33
Reported Net Profit 0.62 -6.08 14.80 32.11 21.34 7.59
Extraordinary Items -0.24 -9.75 15.69 40.89 22.81 6.20
Adjusted Net Profit 0.62 -6.08 14.80 32.11 21.34 7.59
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 0.00 0.00 0.00 0.00 0.00 0.00
Statutory Appropriations 0.00 0.00 0.00 12.42 0.00 4.94
P & L Balance carried down 0.62 -6.08 14.80 32.11 21.34 7.59
Dividend - - - - - -
Preference Dividend - - - - - -
Equity Dividend (%) 0.00 0.00 0.00 25.00 0.00 10.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.50 0.00 0.20
Earnings Per Share-Unit Curr 0.03 -0.24 0.60 1.30 0.88 0.31
Book Value 0.00 0.00 0.00 12.42 0.00 4.94
Book Value(Adj)-Unit Curr 0.00 0.00 0.00 12.42 0.00 4.94

Shareholding Pattern

  • Promoter Group

    52.61%

  • Public Share Holding

    47.23%

  • Custodian

    0.16%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 131,680,103 52.61 131,680,103 1
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 131,680,103 52.61 131,680,103 1
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 0 0.00 0 0
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 0 0.00 0 0
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 15,260,385 6.10 15,260,385 53
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 23,976,741 9.58 23,976,741 7
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 6,097,256 2.44 6,097,256 13
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 45,334,382 18.11 45,334,382 73
2] Non Institution
Bodies Corporate 7,305,047 2.92 7,305,047 927
Clearing Members 8,463 0.00 8,463 8
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 3,442,797 1.38 3,442,797 2,718
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 2,462,617 0.98 2,462,617 2,206
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 6,711,633 2.68 6,711,633 32
Individuals holding nominal share capital up to Rs. 1 lakh 52,916,213 21.14 52,878,708 156,604
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 5,590 0.00 5,590 3
Others 22,900 0.01 22,900 1
Sub Total 72,875,260 29.11 72,837,755 162,499
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 412,250 0.16 412,250 1
Total Shares held by Custodians and against which Depository Receipts have been issued 412,250 0.16 412,250 1
Grand Total ( A + B + C ) 250,301,995 100.00 250,264,490 162,574

Company Background

Sequent Scientific LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Sequent Scientific Ltd
  • BSE Code : 2086.0
  • ISIN : INE807F01027

  • Incorporation Year

    1985

  • Registered Office

    301 Dosti Pinnacle 3rd Floor
    Plot E7 Road No 22 Wagle Indl, Thane,
    Maharashtra-400604

  • Telephone

    91-022-41114777

  • FAX

    91-022-41114754

  • Chairman

    Kamal K Sharma

  • Managing Director

    Sharat Narasapur

  • Company Secretary

    PHILLIP TROTT

  • Auditor

    SRBC & Co LLP

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    Adroit Corp. Services Pvt Ltd
    19/20 Jaferbhoy Ind,
    1st Floor Makwana Rd,Marol Naka
    Mumbai - Mumbai - 400 059

Sequent Scientific Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Sequent Scien. 142.70 214.50 168.52 233.93 0.52
Abbott India 29,940.35 6,097.18 5,848.91 47.68 44.71
Astrazeneca Phar 8,092.00 1,330.33 1,295.53 208.61 33.26
P & G Health Ltd 5,295.80 1,166.89 1,151.26 37.16 39.76
Glaxosmi. Pharma 2,857.90 3,530.73 3,407.25 56.83 44.44
Cipla 1,495.15 17,645.00 16,574.34 25.63 20.10
Amrutanjan Healt 666.30 437.58 421.23 39.06 20.84
Fermenta Biotec. 305.85 315.24 307.09 28.99 4.10
Guj. Themis Bio. 282.25 174.19 169.82 58.44 44.82
Bliss GVS Pharma 126.20 638.96 605.46 28.88 11.19
Ambalal Sarabhai 40.33 11.70 3.81 17.24 1.92